{"title": "Technology Offers", "author": null, "url": "https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/technology-offers/", "hostname": "helmholtz-hzi.de", "description": "Technology offerings of the \"Vaccinology and Applied Microbiology\" department.", "sitename": "Helmholtz Centre for Infection Research", "date": "2022-04-10", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Vaccinology and applied Microbiology\nVaccination is the most efficient strategy to prevent infectious diseases. The art of the\n[vaccine](/en/info-centre/glossary/entry/vaccine/) researcher lies in finding substances that prevent us from falling ill with diseases such as [influenza](/en/info-centre/glossary/entry/influenza/) or viral [hepatitis](/en/info-centre/glossary/entry/hepatitis/). But what makes a [vaccine](/en/info-centre/glossary/entry/vaccine/) successful and ensures effective protection? Our scientists study the reaction of the [immune system](/en/info-centre/glossary/entry/immune-system/) to answer that question \u2013 and to develop better [vaccination](/en/info-centre/glossary/entry/vaccination/) strategies.\nLeader\nTechnology Offers\nThe Mucosal Adjuvant Platform of the HZI Department of Vaccinology, provides expertise, technology and infrastructure in the fields of adjuvants, immune modulators and formulation, including mucosal adjuvants. Our experts in mucosal\n[vaccine](/en/info-centre/glossary/entry/vaccine/) delivery have established [in vitro](/en/info-centre/glossary/entry/in-vitro/) and [in vivo](/en/info-centre/glossary/entry/in-vivo/) models to assess the activity of adjuvants and [vaccine](/en/info-centre/glossary/entry/vaccine/) formulations on innate and adaptive immune cells, as well their capacity to stimulate different clearance effector mechanisms. The team has access to state-of-the-art laboratories and animal facilities with BSL2 and BSL3 containment, [flow cytometry](/en/info-centre/glossary/entry/flow-cytometry/) and sorting facilities and [in vivo](/en/info-centre/glossary/entry/in-vivo/) imaging (IVIS).\nThe HZI Department of Vaccinology provides mucosal adjuvants and advanced immune monitoring and consulting services for the\n[vaccine](/en/info-centre/glossary/entry/vaccine/) community worldwide (academic and industry), including advanced [immune system](/en/info-centre/glossary/entry/immune-system/) monitoring (e.g. 13 colour multiparametric analysis by [flow cytometry](/en/info-centre/glossary/entry/flow-cytometry/), [in vivo](/en/info-centre/glossary/entry/in-vivo/) CTL assays) and biomarkers.\nNews\nBachelor & Master\nAre you interested in a bachelor or master thesis? We are looking forward to your request!\nVideo\nAudio Podcast\n- Ein neuer Impfstoff gegen Tuberkulose \u2013 die Infektion Nr. 1 in der WeltAlle 15 Sekunden stirbt ein Mensch an Tuberkulose. Bislang gibt es keinen ausreichend wirksamen Impfstoff gegen das Mycobacterium tuberkulosis, lediglich einen, der S\u00e4uglinge in den ersten zwei Lebensjahren sch\u00fctzt. Jetzt kristallisiert sich in klinischen Studien ein vielversprechender neuer Impfstoff heraus, den die Vakzine Projekt Management GmbH auf ihrem Weg zur Zulassung begleitet. Bernd Eisele und Leander Grode stellen Ihnen den Impfstoff vor und berichten von ihren Hoffnungen und Erwartungen\u2026\n- Turbo f\u00fcr die Impfung \u2013 neue Hilfsstoffe erm\u00f6glichen neue Impfmethoden Sie habe einen schlechten Ruf, aber ohne sie geht nichts: Impfverst\u00e4rker. Seit es Impfungen gibt, brauchen Impfstoff die Unterst\u00fctzung kleiner Molek\u00fcle. Thomas Ebensen und Rimma Libanova haben einen vielversprechenden Impfturbo entdeckt \u2013 der ganz nebenbei die gesamte Impftechnik revolutionieren k\u00f6nnte. Kommen Sie mit...\n- Influenza zwischen Schwein und Mensch - die Experten Klaus Schughart und Carlos Guzman im Gespr\u00e4ch Die Influenzawelle rollt, aber die Informationen \u00fcber Schweinegrippe, saisonale Grippe und die verschiedenen Impfstoffe sind verwirrend - teilweise be\u00e4ngstigend. Soll ich mich impfen lassen? Sind die Impfstoffe sicher? Mein Nachbar kennt aber jemanden... Die Grippe ist doch gar nicht so schlimm... Sind Sie ebenfalls unsicher? Dann lassen Sie sich die wichtigsten Fragen von unseren Experten des Helmholtz-Zentrums f\u00fcr Infektionsforschung f\u00fcr Influenza Klaus Schughart und Carlos Guzman beantworten...\n- SchnupfimpfungImpfen ohne Spritze. Darauf warten nicht nur Spritzen-Phobiker. Nasensprays sollen in Zukunft das Impfen revolutionieren. Doch es gibt ein gro\u00dfes Problem: Der Impfstoff muss zuerst durch die wehrhafte Schleimhaut, um zu seinem Ziel zu gelangen.\n[Send per email](mailto:?subject=&body=https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/technology-offers/)Share", "language": null, "image": "https://www.helmholtz-hzi.de/fileadmin/user_upload/Forschung/Forschungsgruppen/Vakzinologie/Pipettieren.jpg", "pagetype": null, "links": ["/en/", "/de/forschung/forschungsschwerpunkte/immunantwort-und-interventionen/vakzinologie-und-angewandte-mikrobiologie/technologieangebote/", "/en/the-hzi/", "/en/the-hzi/about-the-hzi/facts-and-figures/", "/en/the-hzi/about-the-hzi/the-hzi/", "/en/the-hzi/about-the-hzi/facts-and-figures/", "/en/the-hzi/about-the-hzi/research-reports/", "/en/the-hzi/about-the-hzi/history-1965-2006/", "/en/the-hzi/about-the-hzi/history-since-2006/", "/en/the-hzi/management/executive-management/", "/en/the-hzi/administration-infrastructure/", "/en/the-hzi/organisation-chart/", "/en/the-hzi/sites/", "/en/the-hzi/360-tour/", "/en/the-hzi/helmholtz-association/", "http://helmholtz-hzi.bibliotheca-open.de/Welcome", "/en/the-hzi/conference-building/", "/en/the-hzi/friends-of-the-hzi/", "/en/the-hzi/mission-statement/", "/en/the-hzi/gender-equality/gender-equality/", "/en/the-hzi/conflict-resolution/", "/en/the-hzi/donation/", "/en/research/research-topics/", "/en/research/mission/", "/en/research/our-research/", "/en/research/research-topics/", "/en/research/research-topics/bacterial-and-viral-pathogens/", "/en/research/research-topics/immune-response/", "/en/research/research-topics/anti-infectives/", "/en/research/research-foci/", "/en/research/research-foci/antimicrobial-resistance-amr/", "/en/research/research-foci/microbial-communities-mico/", "/en/research/research-foci/chronic-viral-infections-cvir/", "/en/research/research-foci/individualized-immune-interventions-indi/", "/en/research/research-foci/digital-and-global-health-epi/", "/en/research/research-foci/infection-and-neurodegeneration-ineu/", "/en/research/research-foci/respiratory-viral-infections-rvir/", "/en/research/research-groups/", "/en/research/technology-platforms/", "/en/research/innovation-management/", "/en/research/cooperations/research-partners/", "/en/research/publication-database/", "/en/research/good-scientific-practice/", "/fileadmin/user_upload/Infothek/Roadmap_HZI_2025/Roadmap_engl_2016_WEB_ES.pdf", "/en/research/translational-research/", "/fileadmin/user_upload/Infothek/Ueber_das_HZI/Jahresberichte/Ergebnisberichte/WEB_HZI_RReport_2022_9MB.pdf", "/fileadmin/user_upload/Infothek/Ueber_das_HZI/Jahresberichte/Ergebnisberichte/WEB_HZI_RReport_2022_9MB.pdf", "/en/career/", "/en/career/jobs/open-positions/", "/en/career/jobs/open-positions/", "/en/career/jobs/phd-theses/", "/en/career/jobs/bachelor-and-master-thesis/", "/en/career/career-paths/", "/en/career/graduate-school/application/", "/en/career/phd-programme-epidemiology/objectives/", "/en/career/embl-hzi-fellowship/general-information/", "/en/career/hzi-mcgill-exchange-program/about-the-program/", "/en/career/do-it-phd-initiative/what-we-do/", "/en/career/hzi-alumni/aims/", "/en/career/pupils/apprenticeships/", "/en/career/career-paths/", "/en/press/", "/en/press/press-releases-news/", "/en/press/gallery-download/", "/en/press/press-kit-josef-penninger/", "/en/press/media-coverage/", "/en/service/newsletter/", "/en/press/press-contacts/", "/en/press/videos-podcasts/videos/", "/en/press/magazine-infact/recent-issue/", "/en/press/brochures/", "/en/press/visitors-service/", "/en/press/press-kit-josef-penninger/", "/en/press/press-kit-josef-penninger/", "/en/info-centre/", "/en/info-centre/topics/all-topics/", "/en/info-centre/topics/germs-and-diseases/", "/en/info-centre/topics/our-immune-system/", "/en/info-centre/topics/anti-infectives/", "/en/press/videos-podcasts/videos/", "/en/info-centre/glossary/", "/en/info-centre/topics/germs-and-diseases/coronaviruses/", "/en/news-events/", "/en/news-events/news/", "/en/news-events/events/", "/en/news-events/research-awards/paper-of-the-month/", "/en/news-events/projects/", "/en/news-events/projects/discourse-animals-in-research/", "/en/news-events/stories/", "/en/news-events/stories/world-day-for-laboratory-animals-and-alternative-models/", "/en/news-events/stories/world-antibiotic-awareness-week-2022/", "/en/news-events/stories/one-health-triad-of-environmental-animal-and-human-health/", "/en/news-events/interview/", "/en/news-events/interview/martin-korte-long-covid-can-become-manifest-even-after-a-mild-course-of-covid-19/", "/en/news-events/interview/peggy-riese-the-corona-vaccines-were-meant-to-protect-against-severe-disease-and-that-is-what-they-do/", "/en/news-events/portrait/", "/en/news-events/portrait/christian-sieben-a-biologist-with-nano-vision/", "/en/news-events/portrait/susanne-talay-a-little-outbreak-every-day/", "/en/news-events/portrait/antoine-emmanuel-saliba-shining-a-spotlight-on-the-cellular-mechanism/", "/en/news-events/stories/coronavirus-sars-cov-2/", "/en/news-events/stories/coronavirus-sars-cov-2/", "/en/", "/en/research/research-topics/", "/en/research/research-topics/", "/en/research/research-topics/immune-response/", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/our-research/", "/en/info-centre/glossary/entry/vaccine/", "/en/info-centre/glossary/entry/influenza/", "/en/info-centre/glossary/entry/hepatitis/", "/en/info-centre/glossary/entry/vaccine/", "/en/info-centre/glossary/entry/immune-system/", "/en/info-centre/glossary/entry/vaccination/", null, "tel:+49-531-6181-4600", "/en/nc/service/contact/person/carlos-a-guzman/", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/our-research/#anchorsection", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/carlos-a-guzman/#anchorsection", "/en/nc/research/research-topics/immune-response/vaccinology-and-applied-microbiology/team/#anchorsection", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/projects/#anchorsection", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/further-groups-of-the-department/#anchorsection", "/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/publications/#anchorsection", "/en/info-centre/glossary/entry/vaccine/", "/en/info-centre/glossary/entry/in-vitro/", "/en/info-centre/glossary/entry/in-vivo/", "/en/info-centre/glossary/entry/vaccine/", "/en/info-centre/glossary/entry/flow-cytometry/", "/en/info-centre/glossary/entry/in-vivo/", "/en/info-centre/glossary/entry/vaccine/", "/en/info-centre/glossary/entry/immune-system/", "/en/info-centre/glossary/entry/flow-cytometry/", "/en/info-centre/glossary/entry/in-vivo/", "https://www.ascenion.de/technologieangebote/Cyclic-di-Nucleotides-as-adjuvants-6214", "https://www.ascenion.de/technologieangebote/Hexosylceramides-as-adjuvants-6216", "https://www.ascenion.de/technologieangebote/Innovative-lipopeptide-conjugates-as-mucosal-adjuvants---BPPcysPep-MPEG-6251", "https://www.ascenion.de/technologie/phytosphingosine-derivatives-as-adjuvants-in-immune-stimulation", "https://www.ascenion.de/technologieangebote/Cyclic-di-AMP:-a-promising-adjuvant-for-neonatal-vaccines-6697", "/en/news-events/news/view/article/complete/forschungskooperation-zu-neuartigen-impfstoffen-gegen-krankheitserreger-der-magen-darm-schleimhaut-g/", "/en/news-events/news/view/article/complete/infektionserreger-bietet-schutz-vor-leberkrebs/", "/en/news-events/news/view/article/complete/antiviral-und-entzuendungshemmend0/", "javascript:if(window.print)window.print()", "mailto:?subject=&body=https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/technology-offers/", "https://www.facebook.com/sharer/sharer.php?u=https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/technology-offers/%2F&src=sdkpreparse", "https://twitter.com/intent/tweet?text=Check%20this%20page%20https://www.helmholtz-hzi.de/en/research/research-topics/immune-response/vaccinology-and-applied-microbiology/technology-offers/", "/en/press/", "https://buendnis.niedersachsen.de/startseite/", "https://www.helmholtz-klima.de/en", "https://www.charta-der-vielfalt.de/en/", "https://www.initiative-transparente-tierversuche.de/", "https://www.facebook.com/helmholtz.hzi", "https://twitter.com/Helmholtz_HZI", "https://de.linkedin.com/company/helmholtz-centre-for-infection-research", "https://www.youtube.com/channel/UC1P_GFvzrKeCgD4z4h4sKDQ", "/en/service/feeds/", "/en/service/newsletter/", "tel:+495316181-0", "/en/nc/service/contact/person/helmholtz-centre-for-infection-research-hzi/", "tel:+49531-6181-0", "/en/nc/service/contact/person/helmholtz-centre-for-infection-research-hzi/", "/en/the-hzi/sites/campus-braunschweig/", "tel:+49-531-391-55100", "/en/nc/service/contact/person/braunschweig-integrated-centre-of-systems-biology-brics/", "/en/the-hzi/sites/braunschweiger-integrated-centre-of-systems-brics/about-brics/", "tel:+49-511-220027-0", "/en/nc/service/contact/person/twincore-centre-for-experimental-and-clinical-infection-research/", "/en/the-hzi/sites/twincore-centre-for-experimental-and-clinical-infection-research/about-twincore/", "tel:+49-511-5350-8500", "/en/nc/service/contact/person/hzi-study-centre/", "/en/the-hzi/sites/study-centre-crc/", "tel:+49-511-5350-8658", "/en/nc/service/contact/person/centre-for-individualised-infection-medicine-ciim/", "/en/the-hzi/sites/centre-for-individualised-infection-medicine-ciim/", "tel:+49-40-8998-3672", "/en/nc/service/contact/person/centre-for-structural-systems-biology-cssb/", "/en/the-hzi/sites/centre-for-structural-systems-biology-cssb/", "tel:+49-681-98806-0", "/en/nc/service/contact/person/helmholtz-institute-for-pharmaceutical-research-saarland-hips/", "/en/the-hzi/sites/helmholtz-institute-for-pharmaceutical-research-saarland-hips/about-hips/", "tel:+49-931-31-89587", "mailto:info@helmholtz-hiri.de", "/en/the-hzi/sites/helmholtz-institute-for-rna-based-infection-research-hiri/", "tel:+49-3834-420-5501", "mailto:hioh-info@helmholtz-hzi.de", "/en/the-hzi/sites/helmholtz-institute-for-one-health-hioh/", "/en/the-hzi/sites/campus-braunschweig/", "/en/the-hzi/sites/braunschweiger-integrated-centre-of-systems-brics/about-brics/", "/en/the-hzi/sites/helmholtz-institute-for-pharmaceutical-research-saarland-hips/about-hips/", "/en/the-hzi/sites/twincore-centre-for-experimental-and-clinical-infection-research/about-twincore/", "/en/the-hzi/sites/study-centre-crc/", "/en/the-hzi/sites/centre-for-individualised-infection-medicine-ciim/", "/en/the-hzi/sites/centre-for-structural-systems-biology-cssb/", "/en/the-hzi/sites/helmholtz-institute-for-one-health-hioh/", "/en/the-hzi/sites/helmholtz-institute-for-rna-based-infection-research-hiri/", "/en/nc/service/contact/", "/en/service/imprint/", "/en/service/sitemap/", "/en/service/newsletter/", "/en/service/data-protection/", "https://whistlefox.heuking.de/start/hzi-gmbh/en", "https://www.helmholtz.de"]}